CDC Entreprises Innovation is the venture capital arm of the CDC Entreprises Group. Via its private equity fund FCPR Sciences and Innovation 2001 and associated FCPI, CDC Entreprises Innovation, invests in companies with strong growth potential. The funds seek investments primarily in innovative companies, at early or mid stages, and development-stage companies in search of new rounds of financing. With more than 425 M€ under management, CDC Entreprises Innovation focuses on three technological sectors: information and communication technologies, life sciences and biotechnology and semiconductor industries.

Tempo Capital Partners LLP (“Tempo”) is a London-based specialist investment advisory firm which acquires, manages and realises portfolios of venture capital investments. Tempo is investment adviser currently to a number of funds established in conjunction with leading fund-of-funds firms to acquire venture portfolios in the secondary market. With aggregate capital commitments to these funds amounting to some €200m and some 50 investments overall, Tempo is now a leader in its field in Europe.  

Notable publicly disclosed transactions which have been arranged by Tempo are as follows:

2004 - A fund advised by Tempo acquired the venture assets of WestLB AG, financed by HarbourVest Partners, a global private equity firm with some $20 billion under management.
2005 - Tempo established TempoPark Fund 1 LP, in conjunction with Greenpark Capital, a private equity firm dedicated to the secondary market managing $700 million, to acquire a portfolio of wireless-related venture investments from Siemens AG.
2006 - Tempo established TempoVest Fund II LP, in conjunction with HarbourVest Partners, to acquire the investments formerly held by V2 FCPR.